穿皮冠状动脉干预后的实体静脉缩:关于生物途径的新兴知识
Francesco Pelliccia1, Marco Zimarino2,3, Giampaolo Niccoli4
1Department of Cardiovascular Sciences, University Sapienza, Viale del Policlinico 155, 00161 Rome, Italy.
European heart journal open
|October 9, 2023
概括
穿皮冠状动脉干预 (PCI) 后的静脉静脉复缩 (ISR) 涉及复杂的生物途径. 新的策略,如内皮原生细胞 (EPC) 捕获支架,可以减少复原,并允许更短的双重抗血小板治疗.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 分子生物学分子生物学
背景情况:
- 静脉静脉复缩 (ISR) 仍然是穿皮冠状动脉干预 (PCI) 的重要并发症.
- 尽管药物排泄支架 (DES) 取得了进展,但由于大量接受PCI治疗的人群,ISR发生率仍然很重要.
- 了解ISR潜在的生物途径对于开发新的治疗策略至关重要.
研究的目的:
- 审查对驱动静脉静脉复缩 (ISR) 的生物途径的新兴理解.
- 探索新的治疗方法,以防止DES植入后的复原.
主要方法:
- 文献综述总结了关于ISR病理生理学的当前知识.
- 对参与PCI反应的分子和细胞机制的分析.
- 讨论新兴的支架技术及其对ISR的潜在影响.
主要成果:
- ISR与患者,遗传,解剖学,支架,病变和程序因素有关.
- 常见的病理生理路径包括炎症,过敏和干细胞动员 (特别是内皮前细胞 - - EPC).
- 这些过程导致血管壁愈合,新极度增生或新动脉样硬化.
结论:
- 解开ISR中的关键分子通路对于有效的治疗干预至关重要.
- 捕获EPC的支架显示出促进快速重新内皮质形成的前景.
- 这种方法可以降低支架血栓形成风险,并使双重抗血小板治疗持续时间更短.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20


